Dr. David Stalling is nationally recognized as an industry pioneer and leader in the fields of instrumentation and chromatography. Contributions throughout his career include 15 issued and two provisional patents, 85 published articles, and the successful launch of several new products and companies – including commercializing the NTrainer System and co-founding KCBioMedix, now Innara Health. In addition to his duties as Chief Scientific Officer, David serves on the Board of Directors at Innara Health. Prior to co-founding our company, notable leadership positions and accomplishments in David's career include:

  • Chief Operating Officer of Primus Corporation (now Trinity Biotech)
  • Chief Executive Officer of Laboratory Automation, Inc. (an ABC Laboratories spinoff)
  • Senior Vice President/Co-Founder of ABC Laboratories, Inc., a leader in the field of chromatography 
  • Co-founder of AFFINEX, LLC 
  • Co-developed LabSeek.com, the first e-commerce scientific brokerage to access Fortune 500 R&D capabilities
  • Received Distinguished Scientific Contribution Award for Contribution to Dioxin Methodology, Aug. 2012; International "Dioxin" Symposium, Dioxin2011; Brussels, Belgium

David completed his bachelor's degree in Chemistry and Mathematics from Missouri Valley College. He earned his master's degree and Ph.D. in Analytical Biochemistry at the University of Missouri, where he also completed a NASA Predoctoral Fellowship in Analytical Methodology